Company Quick10K Filing
Superior Drilling Products
10-K 2020-12-31 Filed 2021-03-16
10-Q 2020-09-30 Filed 2020-11-09
10-Q 2020-06-30 Filed 2020-08-11
10-Q 2020-03-31 Filed 2020-05-11
10-K 2019-12-31 Filed 2020-03-18
10-Q 2019-09-30 Filed 2019-11-07
10-Q 2019-06-30 Filed 2019-08-19
10-Q 2019-03-31 Filed 2019-05-09
10-K 2018-12-31 Filed 2019-03-13
10-Q 2018-09-30 Filed 2018-11-09
10-Q 2018-06-30 Filed 2018-08-02
10-Q 2018-03-31 Filed 2018-05-11
10-K 2017-12-31 Filed 2018-03-23
10-Q 2017-09-30 Filed 2017-11-09
10-Q 2017-06-30 Filed 2017-08-11
10-Q 2017-03-31 Filed 2017-05-15
10-K 2016-12-31 Filed 2017-03-31
10-Q 2016-09-30 Filed 2016-11-15
10-Q 2016-06-30 Filed 2016-08-15
10-Q 2016-03-31 Filed 2016-05-16
10-K 2015-12-31 Filed 2016-03-30
10-Q 2015-09-30 Filed 2015-11-13
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-03-31 Filed 2015-05-15
10-K 2014-12-31 Filed 2015-03-31
10-Q 2014-09-30 Filed 2014-11-14
10-Q 2014-06-30 Filed 2014-08-14
8-K 2020-11-18
8-K 2020-11-12
8-K 2020-11-06
8-K 2020-10-23
8-K 2020-08-07
8-K 2020-07-07
8-K 2020-05-06
8-K 2020-04-21
8-K 2020-04-13
8-K 2020-04-07
8-K 2020-03-12
8-K 2020-02-24
8-K 2019-12-30
8-K 2019-11-20
8-K 2019-11-07
8-K 2019-10-29
8-K 2019-07-31
8-K 2019-07-25
8-K 2019-05-09
8-K 2019-03-07
8-K 2019-02-25
8-K 2019-02-20
8-K 2019-02-01
8-K 2018-12-05
8-K 2018-11-21
8-K 2018-11-16
8-K 2018-11-08
8-K 2018-10-17
8-K 2018-08-27
8-K 2018-08-03
8-K 2018-08-03
8-K 2018-08-02
8-K 2018-08-01
8-K 2018-05-10
8-K 2018-04-27
8-K 2018-04-05
8-K 2018-03-08
8-K 2018-01-27

Superior Drilling Products Financials

SDPI Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
ENETI INC. (NETI)
024 Pharma (EEIG)
Vivus (VVUS) 40,869 77% -17.5 -11% 226,103 289,374 72,620 55,706 -24,956 -13,928 243,484
Clovis Oncology (CLVS) 219,222 0% -0.0 -56% 716,892 804,387 134,050 0 -400,184 -394,255 17,741
Cementos Pacasmayo Saa (CPAC) 4,145,433 0% 2,863,245 1,411,882 0 0 0 0 4,145,433
11 Good Energy (ELVN)
Exantas Capital (XAN)
1347 Capital Corp (TFSC)
Bancorp of New Jersey (BKJ) 122,881 1.0 0% 961,684 868,577 0 0 3,422 14,772 14,360
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
1st United Bancorp (FUBC)
2-Track Global (TTG)
ENTERGY ARKANSAS, LLC (EAI)
21st Century Oncology Holdings (RTSX)
24Holdings (TWFH)
30DC (TDCH)
3D Pioneer Systems (DPSM)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash5,9625,7925,7732,4561,9281,2977672123322,2421,0301,3012,7062,3752,1753,0844,2754,2654,3463,2152,792
Accounts Receivable4,2604,4033,5432,1291,9361,8618314741,2121,0392,6562,8752,5332,6673,2233,2092,6292,2732,7793,3134,099
Inventory1,1291,2191,4751,4781,4581,4111,4791,2811,5481,1681,3521,2861,1771,1971,1629451,0351,0041,2321,163960
PP&E19,58220,51020,62920,90221,15521,39521,59221,07118,86515,21815,35015,25915,90615,98116,02816,06516,11016,63016,95117,33017,139
Assets57,71457,54355,84850,15648,57838,75536,27833,77938,95732,98929,78629,45230,36728,67628,21028,14728,32127,00627,38918,98518,475
Accounts Payable8118937505155236395587771,2441,0671,4337476581,0211,0863406597211,3457841,274
Long-Term Debt21,52623,00022,95818,98518,94919,67218,90918,63517,25116,84113,59813,51113,41213,76712,19911,58710,96410,87610,3219,9198,768
Liabilities27,62027,47726,77323,26323,29422,58022,08922,56922,65919,02016,02915,21215,39314,37313,70212,53012,34812,22912,57211,90011,652
Stockholders' Equity30,09430,06629,07626,89325,28416,17514,18911,21016,29813,96813,75814,24014,97414,30314,50815,61615,97314,77714,8187,0856,823
Income Statement ($'000)2014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue5,7516,0874,0752,8813,0182,7331,4451,1142,2612,3333,3705,1584,4473,7304,6005,3994,7655,0364,5435,076
Cost of Revenue1,8052,6141,9211,5851,5221,5921,0211,3329721,1671,1811,7001,7171,5711,7991,9431,6662,0432,0142,063
Gross Profit3,9463,4732,1531,2961,4961,140424-2181,2891,1662,1893,4582,7302,1592,8013,4563,1002,9932,5303,013
R&D
SG&A3,1452,3782,0571,7811,8671,3071,2911,5391,3201,6271,4981,4151,1021,8971,6981,4271,8672,0691,8162,502
Tax-526-78-48021747-25600-2000
Net Income-658-150-1,043-2,236-1,940-9,236-2,243-3,099-1,173-2,614-3861,094586-786691,005225-141-397-418
Cash Flow ($'000)2014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating1,663542-12015548-345-526-610-450-8365201,6661,0095211,877976-47292
Cash Investing-1,232-223-335-343-321-146125189-32,351-8-79-716-95-52-339-347293
Cash Financing-600-338-2,862-339-358-39-1545412,363-2,727-241-182-623-626-635-556-738-1,007